Rizatriptan
(Redirected from Maxalt)
Rizatriptan (Maxalt®) is a triptan drug developed by Merck & Co. for the treatment of migraine headaches. It is available in strengths of 5 and 10 mg as tablets and orally disintegrating tablets.
Rizatriptan is available only by prescription in the United States and Canada.
External Links
| Triptans edit |
|---|
|
{Almotriptan} {Eletriptan} {Frovatriptan} {Naratriptan} {Rizatriptan} {Sumatriptan} {Zolmitriptan} |
| Tryptamines edit |
|---|
|
{4-Acetoxy-DET} {4-Acetoxy-DIPT} {5-MeO-AMT} {5-MeO-DALT} {5-MeO-DET} {5-MeO-DIPT} {5-MeO-DMT} {5-MeO-MIPT} {AET} {AMT} {Baeocystin} {Bufotenin} {DET} {DIPT} {DMT} {DPT} {Ethocin} {Ibogaine} {Iprocin} {Melatonin} {Norbaeocystin} {Psilocin} {Psilocybin} {Rizatriptan} {Serotonin} {Sumatriptan} {Tryptamine} {Tryptophan} |
Categories: Pharmacology stubs | Triptans